Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
collaboration
Salipro Biotech et Boehringer Ingelheim concluent un accord de recherche et de licence en vue d’accélérer plusieurs programmes du pipeline de Boehringer Ingelheim
13 mars 2025 09h00 HE
|
Salipro Biotech AB
STOCKHOLM, 13 mars 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, société suédoise de biotechnologie spécialisée dans la stabilisation de cibles pharmacologiques difficiles à étudier, a annoncé ce...
Salipro Biotech und Boehringer Ingelheim schließen Forschungs- und Lizenzvertrag zur Beschleunigung mehrerer Pipeline-Programme von Boehringer Ingelheim
13 mars 2025 09h00 HE
|
Salipro Biotech AB
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, ein schwedisches Biotechnologieunternehmen, das sich auf die Stabilisierung anspruchsvoller Wirkstoffziele spezialisiert hat, gab...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
13 mars 2025 09h00 HE
|
Salipro Biotech AB
Salipro Biotech and Boehringer Ingelheim enter research and license agreement to accelerate multiple Boehringer Ingelheim pipeline programs.
Egnyte Expands Intelligence Solutions with Deep Research AI, AI Workflows and Agents
12 mars 2025 11h00 HE
|
Egnyte, Inc
MOUNTAIN VIEW, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Egnyte, a leader in secure content collaboration and governance, today announced significant enhancements to its Intelligence solutions. The...
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
21 févr. 2025 08h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
06 févr. 2025 03h00 HE
|
Essential Pharma
Agreement drives continued patient access to four important therapies in Japan and Korea Strengthens Essential Pharma and Clinigen’s combined market presence in the JAPAC region Egham, UK – 6th...
Partnership Aims to Improve Safe Water Access Across Tanzania
28 janv. 2025 10h36 HE
|
Global Water Center
The government of Tanzania and Global Water Center work together to reach millions of Tanzanians who currently lack access to safe water.
IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
22 janv. 2025 08h00 HE
|
IMMvention Therapeutix, Inc.
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a...
2024 Rising Stars Shine at iC³ Summit: Celebrating Progress and Setting the Stage for 2025
30 déc. 2024 10h59 HE
|
BioNTX
DALLAS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The 2024 Rising Stars of the life sciences and healthcare innovation sector took center stage at the iC³ Life Science Summit this year, marking another...
OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production
23 déc. 2024 04h00 HE
|
OBI Pharma Inc.
OBI Pharma collaborates with GlyTech to advance GlycOBI® technologies in Japan, enhancing glycan production and enabling novel ADC therapeutic innovations.